The Travelers Companies has partnered with Samsung Electronics America, Cedars-Sinai, Bayer and appliedVR to test therapeutic virtual reality (VR) and wearable technology for the treatment of acute orthopaedic injuries.

This digital kit will be trialled as a non-pharmacological supplement to manage pain caused due to injuries of the lower back and extremities. It will analyse day-to-day functional status, work productivity and pain medication use.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The 16-month project will be carried out by Cedars-Sinai’s Center for Outcomes Research and Education and Department of Orthopaedic Surgery with 90-140 subjects aged 18-65 years who experienced workplace injuries.

Travelers National Pharmacy director Dr Melissa Burke said: “Workplace injuries that lead to chronic pain can cause ongoing issues, as an injured employee may mask pain with opioids or other drugs.

“Identifying new, non-pharmacologic alternatives for pain management can help an injured employee avoid chronic pain, lower the chances that they will develop a dangerous opioid addiction and reduce medical costs.”

“The 16-month project will be carried out by Cedars-Sinai’s Center for Outcomes Research and Education and Department of Orthopaedic Surgery with 90-140 subjects aged 18-65 years who experienced workplace injuries.”

The new project is based on previous findings by Samsung Electronics America, appliedVR and Cedars-Sinai that revealed the capability of VR to minimise pain in hospitalised patients, offering a non-pharmacologic alternative to opiates.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The pain-reduction kit to be tested in the project will include Oculus-powered Samsung Gear VR and headset, Samsung GearFit2 wearable and therapeutic pain management content backed by appliedVR’s biosensors.

In addition, Bayer will supply AleveDirect Therapy transcutaneous electrical nerve stimulation (TENS) Device for lower back pain from sore and aching muscles associated with strain due to exercise and common household and work activities.

Medical Device Network Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Medical Device Network Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now